Back to top

Microbot Medical price target lowered to $4 from $5 at B. Riley

B. Riley lowered the firm’s price target on Microbot Medical (MBOT) to $4 from $5 and keeps a Buy rating on the shares. Microbot Medical’s Q2 reven...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Microbot Medical Inc. (MBOT)